Formidable Asset Management’s AEON Biopharma AEON Stock Holding History

Formidable Asset Management’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7K	Hold	20,024	–	–	﹤0.01%	385
2026 Q1	$22K	Buy	+20,024	New	+$22.4K	﹤0.01%	378
2025 Q1	–	Sell	-9,572	Closed	-$372K	–	385
2024 Q4	$372K	Buy	9,572 +4,158	+77%	+$242K	0.06%	270
2024 Q3	$409K	Buy	5,414 +3,836	+243%	+$338K	0.07%	251
2024 Q2	$119K	Buy	1,578 +631	+67%	+$150K	0.02%	380
2024 Q1	$791K	Buy	947 +139	+17%	+$101K	0.13%	163
2023 Q4	$419K	Sell	808 -85	-10%	-$34.1K	0.09%	190
2023 Q3	$360K	Buy	+893	New	+$409K	0.08%	207

Other funds holding AEON

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Formidable Asset Management's AEON Position: Q2 2026 in Review

Formidable Asset Management held its AEON Biopharma (AEON) position steady in Q2 2026 at 20,024 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Formidable Asset Management first reported a position in AEON in Q3 2023 and has held it in 8 quarters since. The position peaked at $791K in Q1 2024. 3 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

Formidable Asset Management held 20,024 shares of AEON Biopharma worth $19.7K as of Q2 2026.
Formidable Asset Management left its AEON Biopharma share count unchanged in Q2 2026.
AEON Biopharma made up ﹤0.01% of Formidable Asset Management's portfolio in Q2 2026, its #385 holding.
Formidable Asset Management first reported a position in AEON Biopharma in Q3 2023 and has held it in 8 quarters since.
Formidable Asset Management's AEON Biopharma position peaked at $791K in Q1 2024.
3 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.